Redefining cancer with AI to generate precision immunotherapies
Reductionism fails to capture the emergent complexity of tumor-immune interactions
Machine learning adds that complexity back into drug discovery
Noetik combines self-supervised learning with the industrial-scale generation of human multimodal data — because the best model system for cancer is the patient
This enables the creation of foundation models for cell and tissue biology that drive therapeutic development
— we’re entering a new era of self-supervised science
We're building toward a future of precision immunotherapies that begin with the patient — Join us. Explore careers ›
